UrologyNews.net

Urology Xagena

Search results for "Bladder"

Researchers at University of Pittsburgh have isolated two biomarkers for interstitial cystitis ( IC ). According to the National Institute of Diabetes and Digestive and Kidney Diseases, 700,000 Ame ...


A commonly prescribed incontinence drug may help patients in more than one way, according to research carried out at University of Pittsburgh. When taken orally, Trospium chloride ( Sanctura ) not ...


Researchers at Mayo Clinic studying prostate problems in men report in the Journal of Urology that as men grow older their bladder function can worsen and the prostate gland may be responsible. T ...


Patients with early bladder cancer who receive more intensive treatment within the first two years of diagnosis do not appear to have better survival than patients who receive less intensive treatment ...


Adding chemotherapy to radiation therapy for muscle invasive bladder cancer allows 67% of people to be free of disease in their bladders two years after treatment. This compares to 54% of people who r ...


Researchers has assessed effectiveness, safety, and tolerability of Paclitaxel or Fluorouracil when added to radiation plus Cisplatin followed by adjuvant chemotherapy in a programme of selected bladd ...


A study, published in the Journal of Clinical Sleep Medicine, suggests that the bladder condition nocturia may worsen the already poor sleep of older adults with insomnia.The research has involved a g ...


Ipsen has announced positive results from its phase IIa clinical trial assessing Dysport in the treatment of neurogenic detrusor overactivity ( NDO ) in patients with urinary incontinence not adequate ...


Around 16% to 45% of adults have overactive bladder symptoms, urgency with frequency or urgency urinary incontinence, or both, termed overactive bladder syndrome. Anticholinergic drugs are common trea ...


Results from a phase I open-label study that showed the investigational cancer immunotherapy MPDL3280A ( anti-PDL1 ) shrank tumours ( overall response rate ) in 43% ( 13/30 ) of people previously trea ...


The identification of biomarkers in urine or serum samples from patients with bladder cancer is urgently required for the development of non-invasive methods for the diagnosis of bladder carcinoma and ...


In the IMvigor 210 study, the investigational cancer immunotherapy Atezolizumab ( MPDL3280A; anti-PD-L1 ) shrank tumors ( objective response rate; ORR; the primary end point of this study ) in people ...


About one half of all bladder neoplasms are non-invasive, and in those, the histologic grade is a crucial prognosticator. Few single-Center studies have assessed the recurrence, progression, and can ...


Typically in invasive papillary urothelial carcinoma both the overlying papillary and the invasive components are high grade. Researches have described a series of patients with invasive low-grade ...


A study has investigated the clinical and urodynamic features of patients with lower urinary tract symptoms/benign prostatic hyperplasia ( LUTS/BPH ) according to their prostate size. Researchers a ...